- Secondary Prophylaxis of Docetaxel Induced Diarrhea with Loperamide: Case Report
-
Lee HY, Lee YH, Kim MJ, Kim HK
- KMID: 1777697
- J Korean Med Sci.
- 2013 Oct;28(10):1549-1551.
- doi: 10.3346/jkms.2013.28.10.1549
Diarrhea is a common adverse event of docetaxel with 20%-40% of incidence and severe diarrhea occurs in 5%-6%. Several treatment guidelines for chemotherapy induced diarrhea (CID) exist, however the prophylaxis... -
- CITED
-
- Close
- SHARE
-
- Close
- 14-3-3ζ Overexpression is Associated with Poor Prognosis in Ovarian Cancer
-
Kim HJ, Sung SH, Kim CY, Bae MK, Cho MS, Kim YH, Kim SC, Ju W
- KMID: 2418848
- Yonsei Med J.
- 2018 Jan;59(1):51-56.
- doi: 10.3349/ymj.2018.59.1.51
PURPOSE: 14-3-3ζ regulates cell signaling, cell cycle progression, and apoptosis, and its overexpression is associated with disease recurrence and poor clinical outcomes in some solid tumors. However, its clinicopathological role... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult
-
Park KW, Seo CJ, Yun DY, Kim MK, Kim BS, Han YS, Oh HK, Lee CH
- KMID: 2351031
- Clin Mol Hepatol.
- 2015 Sep;21(3):300-308.
- doi: 10.3350/cmh.2015.21.3.300
Hepatoblastoma usually occurs in children under the age of 2 years, with very few cases reported in adults. We experienced a case of adult hepatoblastoma in a 36-year-old female with... -
- CITED
-
- Close
- SHARE
-
- Close
- Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer
-
Joung JY, Han KS, Kim TS, Seo HK, Chung J, Lee KH
- KMID: 1785816
- J Korean Med Sci.
- 2008 Aug;23(4):598-603.
- doi: 10.3346/jkms.2008.23.4.598
The authors designed this study to determine the clinical effectiveness of trimodality treatment, i.e., transurethral resection of a bladder tumor (TURBT) and concurrent chemoradiotherapy (CRT). Twenty patients with a muscle-invasive... -
- CITED
-
- Close
- SHARE
-
- Close
- Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy
-
Han DH, Joo DJ, Kim MS, Choi GH, Choi JS, Park YN, Seong J, Han KH, Kim SI
- KMID: 2374176
- Yonsei Med J.
- 2016 Sep;57(5):1276-1281.
- doi: 10.3349/ymj.2016.57.5.1276
Locally advanced hepatocellular carcinoma (HCC) with portal vein thrombosis carries a 1-year survival rate -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Metachronous Development of Esophageal Squamous Cell Carcinoma in the Patient with Esophageal Carcinosarcoma
-
Cha RR, Jung WT, Oh HW, Kim HJ, Ha CY, Kim HJ, Kim TH, Ko GH
- KMID: 2160669
- Korean J Gastroenterol.
- 2014 Dec;64(6):364-369.
- doi: 10.4166/kjg.2014.64.6.364
Esophageal carcinosarcoma is a rare malignant esophageal neoplasm consisting of both carcinomatous and sarcomatous elements, with an incidence of 0.5%. There have been only a few case reports of carcinosarcoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Toxicities and Efficacies of the Combination Chemotherapy Regimens in Advanced Gastric Cancer Patients Who Achieved Complete Response after Chemotherapy
-
Kim YJ, Goh PG, Kim ES, Lee SY, Moon HS, Lee ES, Sung JK, Kim SH, Lee BS, Jeong HY
- KMID: 1043329
- Korean J Gastroenterol.
- 2011 Dec;58(6):311-317.
- doi: 10.4166/kjg.2011.58.6.311
BACKGROUND/AIMS: We retrospectively analyzed comparative toxicities and efficacies of chemotherapy regimens in advanced gastric cancer (AGC) patients who achieved complete response (CR) after chemotherapy. METHODS: We reviewed the medical records of... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma
-
Ji SK, Park NH, Choi HM, Kim YW, Lee SH, Lee KH, Ahn SY, Lee SU, Han BH, Park BC
- KMID: 1038464
- Korean J Intern Med.
- 1996 Jan;11(1):58-68.
To evaluate the clinical efficacy of alpha-interferon(IFN-alpha) plus cis-platinum in hepatocellular carcinoma(HCC). 56 inoperable patients with HCC were divided into IFN-alpha plus cis-platinum treated group (n = 30) and no... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical implications of proliferation activity in T1 or T2 male gastric cancer patients
-
Kim YW, Eom BW, Kook MC, Kim HS, Kim MK, Hwang HL, Chandra V, Poojan S, Song Y, Koh JS, Bae CD, Ro J, Hong KM
- KMID: 2359880
- Exp Mol Med.
- 2015 Nov;47(11):e193.
- doi: 10.1038/emm.2015.79
Proliferation activity has already been established as a prognostic marker or as a marker for anticancer drug sensitivity. In gastric cancer, however, the prognostic significance of proliferation activity is still... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma
-
Yokoi E, Mabuchi S, Takahashi , Matsumoto , Kuroda H, Kozasa K, Kimura T
- KMID: 2413458
- J Gynecol Oncol.
- 2017 Mar;28(2):e19.
- doi: 10.3802/jgo.2017.28.e19
OBJECTIVE: To compare the survival outcomes of patients with cervical squamous cell carcinoma (SCC) and adenocarcinoma/adenosquamous carcinoma (AC/ASC) among patients with locally advanced cervical cancer that were treated with definitive... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Volume Change after Chemotheraphy as a Predictive Factor of Disease Free Survival for Osteosarcoma
-
Moon SH, Shin KH, Suh JS, Yang WI, Noh JK, Hahn SB
- KMID: 2158121
- Yonsei Med J.
- 2005 Feb;46(1):119-124.
- doi: 10.3349/ymj.2005.46.1.119
Change in tumor volume after chemotherapy appears to have a prognostic significance for the outcome of osteosarcoma. A newly developed volume measurement method based on three-dimensional summation with a proved... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Synchronous Esophagus and Stomach Cancer Successfully Treated by Combined Chemotherapy
-
Han JS, Choi SR, Jang JS, Roh MH, Kim DC, Ryu SH, Woo SM, Hsing CT
- KMID: 1387340
- Korean J Gastroenterol.
- 2012 Aug;60(2):113-118.
- doi: 10.4166/kjg.2012.60.2.113
Although cases of simultaneous esophagus and stomach cancer have been reported sporadically, there are rare reports of successful treatment using chemotherapy. We report a case of synchronous esophageal and gastric... -
- CITED
-
- Close
- SHARE
-
- Close
- VEGF as a Predictor for Response to Definitive Chemoradiotherapy and COX-2 as a Prognosticator for Survival in Esophageal Squamous Cell Carcinoma
-
Yoon MS, Nam TK, Lee JS, Cho SH, Song JY, Ahn SJ, Chung IJ, Jeong JU, Chung WK, Nah BS
- KMID: 1777881
- J Korean Med Sci.
- 2011 Apr;26(4):513-520.
- doi: 10.3346/jkms.2011.26.4.513
We investigated the patterns of pretreatment expression of the epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and cyclooxygenase-2 (COX-2) by immunohistochemical staining and determined their correlation with... -
- CITED
-
- Close
- SHARE
-
- Close
